Overview

N-acetylcysteine in the Treatment of Bulimia Nervosa

Status:
Terminated
Trial end date:
2012-03-01
Target enrollment:
Participant gender:
Summary
The specific aim of this study is to evaluate the efficacy, tolerability, and safety of N-acetylcysteine (NAC) in the treatment on bulimia nervosa.
Phase:
Phase 3
Details
Lead Sponsor:
Lindner Center of HOPE
Collaborator:
University of Cincinnati
Treatments:
Acetylcysteine
N-monoacetylcystine